Photodynamic therapy technology destroys colon cancer tumors in mice

When activated by laser light, Theralase Technologies' (Toronto, ON, Canada) anti-cancer photodynamic compound (PDC) technology completely destroyed subcutaneous (under the skin) colon cancer tumors in a mouse model. Four weeks post-treatment, the mice continue to be cancer-free, while those mice that weren't treated with the compound didn't survive for two weeks.
        
In the study, which began in early February, mice were injected under the skin with 350,000 colon cancer cells—when tumors formed, they were allowed to grow until they reached 5 mm in size. Then, on February 21, half the mice were used as a control group where no therapy was administered, while the remaining animals became the treatment group and were administered an intratumor injection of the PDC. At that point the PDC was allowed to distribute within the cancerous tumor for 4 hours, then activated with the company's laser light protocol for 32 minutes.

Twenty-four hours post-treatment, the tumors were no longer visible on the treated mice while tumors in the control mice grew to the maximum allowable size of 12 mm, as determined by the study protocol, and did not survive for longer than 2 weeks. The mice treated with the PDC technology continue to be cancer-free four weeks post-treatment.

Roger Dumoulin-White, Theralase president and CEO, foresees that the PDC technology will enter human clinical trials as early as 2013.

-----

Follow us on Twitter, 'like' us on Facebook, and join our group on LinkedIn

Follow OptoIQ on your iPhone; download the free app here.

Subscribe now to BioOptics World magazine; it's free!

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

Nanoparticles, NIR laser light combine to destroy cancer cells

A newly developed method that kills cancer cells using nanoparticles and near-infrared laser light.

Novel post-op patch delivers drug, gene, and light therapy to tumor sites

An adhesive patch can stick to a tumor site, either before or after surgery, to deliver a combination of drug, gene, and light therapy.

Low-level laser therapy is a potential noninvasive treatment for thrombocytopenia

Low-level laser therapy may offer a noninvasive, drug-free treatment for a potentially life-threatening bleeding disorder.

NIR light-activated nanoparticles can precisely target and treat tumors

Novel nanoparticles that use heat and near-infrared light can potentially target and ablate tumors with greater precision.

BLOGS

Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...

CONNECT WITH US

            

Twitter- BioOptics World